Armistice Capital, LLC, Director, 10% Owner at TENAX THERAPEUTICS, INC. (TENX), bought 32,000 shares at $1.45 ($47K) on 2020-08-31, disclosed to the SEC on 2020-08-31.
Open-market purchase of $47k TENX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 12,000 | $18K | 38.3% |
| 2 | $1.45 | 20,000 | $29K | 61.7% |
| Total | $1.47 avg | 32,000 | $47K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |